These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24407057)

  • 21. In vitro approaches to the identification and characterization of skin sensitizers.
    Basketter D; Maxwell G
    Cutan Ocul Toxicol; 2007; 26(4):359-73. PubMed ID: 18058309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Classification of contact allergens according to potency: proposals.
    Kimber I; Basketter DA; Butler M; Gamer A; Garrigue JL; Gerberick GF; Newsome C; Steiling W; Vohr HW
    Food Chem Toxicol; 2003 Dec; 41(12):1799-809. PubMed ID: 14563405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ranking of hair dye substances according to predicted sensitization potency: quantitative structure-activity relationships.
    Søsted H; Basketter DA; Estrada E; Johansen JD; Patlewicz GY
    Contact Dermatitis; 2004; 51(5-6):241-54. PubMed ID: 15606648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skin Sensitization Tests: The LLNA and the RhE IL-18 Potency Assay.
    Corsini E; Gibbs S; Roggen E; Kimber I; Basketter DA
    Methods Mol Biol; 2021; 2240():13-29. PubMed ID: 33423223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transfer of a two-tiered keratinocyte assay: IL-18 production by NCTC2544 to determine the skin sensitizing capacity and epidermal equivalent assay to determine sensitizer potency.
    Teunis M; Corsini E; Smits M; Madsen CB; Eltze T; Ezendam J; Galbiati V; Gremmer E; Krul C; Landin A; Landsiedel R; Pieters R; Rasmussen TF; Reinders J; Roggen E; Spiekstra S; Gibbs S
    Toxicol In Vitro; 2013 Apr; 27(3):1135-50. PubMed ID: 22728231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A quantitative approach to assess the potency of skin sensitizers in the elicitation phase.
    Ezendam J; Vermeulen JP; de Klerk A; de Jong WH; van Loveren H
    Toxicology; 2012 Sep; 299(1):20-4. PubMed ID: 22564262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does irritation potency contribute to the skin sensitization potency of contact allergens?
    Basketter DA; Kan-King-Yu D; Dierkes P; Jowsey IR
    Cutan Ocul Toxicol; 2007; 26(4):279-86. PubMed ID: 18058302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compilation of historical local lymph node data for evaluation of skin sensitization alternative methods.
    Gerberick GF; Ryan CA; Kern PS; Schlatter H; Dearman RJ; Kimber I; Patlewicz GY; Basketter DA
    Dermatitis; 2005 Dec; 16(4):157-202. PubMed ID: 16536334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of the local lymph node assay for the estimation of relative contact allergenic potency.
    Basketter DA; Balikie L; Dearman RJ; Kimber I; Ryan CA; Gerberick GF; Harvey P; Evans P; White IR; Rycroft RJ
    Contact Dermatitis; 2000 Jun; 42(6):344-8. PubMed ID: 10871098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.
    Gerberick GF; Ryan CA; Dearman RJ; Kimber I
    Methods; 2007 Jan; 41(1):54-60. PubMed ID: 16938465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The local lymph node assay compared with the human maximization test as an indicator of allergic potency in humans using patch test clinic populations.
    Zaghi D; Maibach HI
    Cutan Ocul Toxicol; 2009; 28(2):61-4. PubMed ID: 19514928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The local lymph node assay and skin sensitization testing.
    Kimber I; Dearman RJ
    Methods Mol Biol; 2010; 598():221-31. PubMed ID: 19967517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potency values from the local lymph node assay: application to classification, labelling and risk assessment.
    Loveless SE; Api AM; Crevel RW; Debruyne E; Gamer A; Jowsey IR; Kern P; Kimber I; Lea L; Lloyd P; Mehmood Z; Steiling W; Veenstra G; Woolhiser M; Hennes C
    Regul Toxicol Pharmacol; 2010 Feb; 56(1):54-66. PubMed ID: 19733604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of sensitive mouse lymph node assay for detection of contact sensitization capacity of dyes.
    Ikarashi Y; Tsuchiya T; Nakamura A
    J Appl Toxicol; 1996; 16(4):349-54. PubMed ID: 8854222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Updating the skin sensitization in vitro data assessment paradigm in 2009.
    Basketter DA; Kimber I
    J Appl Toxicol; 2009 Aug; 29(6):545-50. PubMed ID: 19484705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skin sensitization: strategies for the assessment and management of risk.
    Basketter DA
    Br J Dermatol; 2008 Aug; 159(2):267-73. PubMed ID: 18503602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantifying skin sensitization potency.
    Roberts DW
    Contact Dermatitis; 2012 Jun; 66(6):356-7. PubMed ID: 22568851
    [No Abstract]   [Full Text] [Related]  

  • 38. A chemical dataset for evaluation of alternative approaches to skin-sensitization testing.
    Gerberick GF; Ryan CA; Kern PS; Dearman RJ; Kimber I; Patlewicz GY; Basketter DA
    Contact Dermatitis; 2004 May; 50(5):274-88. PubMed ID: 15209809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative and mechanistic read across for predicting the skin sensitization potential of alkenes acting via Michael addition.
    Enoch SJ; Cronin MT; Schultz TW; Madden JC
    Chem Res Toxicol; 2008 Feb; 21(2):513-20. PubMed ID: 18189367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The local lymph node assay in 2014.
    Basketter DA; Gerberick GF; Kimber I
    Dermatitis; 2014; 25(2):49-50. PubMed ID: 24603516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.